Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
SFEM Hussein
Observed name:
S.F.E.M. Hussein
OpenAlex ID:
A5113026515
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Recovery from COVID19 is Associated With An Increase In CD3+, CD4+and CD8+T-cells During The Course of Disease
2021
·
SFEM Hussein
, Matthew McKnight Croken
, et al.
·
Modern Pathology
Show more works
View as search
Works count:
5
Citation count:
58
H-index:
3
I10-index:
2
Year
Topic
Type
